SCHEMBL22654094

SCHEMBL22654094

C=Cc1ccc(-c2cc(N)c(N)c(-c3ccc(C=C)cc3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
HDAC2 Q92769 1/20 0.38
DAPK3 O43293 1/20 0.33
JAK2 O60674 1/20 0.33
ABL1 P00519 1/20 0.33
NTRK1 P04629 1/20 0.33
FYN P06241 1/20 0.33
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33
MET P08581 1/20 0.33
PDGFRB P09619 1/20 0.33
FGFR1 P11362 1/20 0.33
FLT3 P36888 1/20 0.33
MAPK8 P45983 1/20 0.33
GSK3B P49841 1/20 0.33
CDK9 P50750 1/20 0.33
RPS6KA3 P51812 1/20 0.33
LIMK1 P53667 1/20 0.33
MAP2K1 Q02750 1/20 0.33
NTRK3 Q16288 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23464382 0.81 ALDH1A1 (0.44) ALDH1A1HDAC2DAPK3JAK2ABL1
SCHEMBL30560581 0.76 ALDH1A1 (0.48) ALDH1A1HDAC2DAPK3JAK2ABL1
SCHEMBL22654098 0.76 TDP1 (0.44) ALDH1A1HDAC2TSHRMEN1KMT2A
SCHEMBL28466430 0.76 ALDH1A1 (0.42) ALDH1A1HDAC2DAPK3JAK2ABL1
SCHEMBL16180699 0.75 ALDH1A1 (0.65) ALDH1A1HDAC2DAPK3JAK2ABL1
SCHEMBL20495275 0.75 IKBKB (0.50) ALDH1A1DAPK3ABL1NTRK1FYN
SCHEMBL17841698 0.74 HSD17B10 (0.50) ALDH1A1MEN1KMT2ATDP1IKBKB
SCHEMBL29904187 0.74 HSD17B10 (0.50) ALDH1A1MEN1KMT2ATDP1IKBKB
SCHEMBL27801363 0.73 ALDH1A1 (0.44) ALDH1A1HDAC2DAPK3JAK2ABL1
SCHEMBL31298969 0.73 ALDH1A1 (0.61) ALDH1A1HDAC2DAPK3JAK2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737682-B1 C2-C3-ALKENYL-SUBSTITUTED RYLENE IMIDE DYES AND CURING PRODUCT OF CURABLE SILICON RESIN COMPOSITION AND C2-C3-ALKENYL-SUBSTITUTED RYLENE IMIDE DYES BASF SE (DE) 2025-12-17 EP disclosed
US-11987738-B2 C2-C3-alkenyl-substituted rylene imide dyes and curing product of curable silicon resin composition and C2-C3-alkenyl-substituted rylene imide dyes BASF SE (DE) 2024-05-21 US disclosed
CN-111699186-B C 2 -C 3 Alkenyl substituted ruimide dyes, curable silicone compositions and C 2 -C 3 Cured products of alkenyl substituted ruimide dyes 巴斯夫欧洲公司 2024-03-05 CN disclosed
US-20200362235-A1 C2-C3-ALKENYL-SUBSTITUTED RYLENE IMIDE DYES AND CURING PRODUCT OF CURABLE SILICON RESIN COMPOSITION AND C2-C3-ALKENYL-SUBSTITUTED RYLENE IMIDE DYES BASF SE (DE) 2020-11-19 US disclosed
EP-3737682-A2 C2-C3-ALKENYL-SUBSTITUTED RYLENE IMIDE DYES AND CURING PRODUCT OF CURABLE SILICON RESIN COMPOSITION AND C2-C3-ALKENYL-SUBSTITUTED RYLENE IMIDE DYES BASF SE (DE) 2020-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11987738-B2 C2-C3-alkenyl-substituted rylene imide dyes and curing product of curable silicon resin composition and C2-C3-alkenyl-substituted rylene imide dyes RTN3, C9, RER1 ALDH1A1 814/4885HDAC2 710/4885DAPK3 2820/4885
US-20200362235-A1 C2-C3-ALKENYL-SUBSTITUTED RYLENE IMIDE DYES AND CURING PRODUCT OF CURABLE SILICON RESIN COMPOSITION AND C2-C3-ALKENYL-SUBSTITUTED RYLENE IMIDE DYES RTN3, C9, RER1 ALDH1A1 814/4885HDAC2 710/4885DAPK3 2820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.